tiprankstipranks
Trending News
More News >
Sabra Healthcare Reit (DE:SBC)
NASDAQ:SBC
Germany Market

Sabra Healthcare REIT (SBC) Earnings Dates, Call Summary & Reports

Compare
0 Followers

Earnings Data

Report Date
May 06, 2026
TBA (Confirmed)
Period Ending
2026 (Q1)
Consensus EPS Forecast
0.14
Last Year’s EPS
0.14
Same Quarter Last Year
Moderate Buy
Based on 9 Analysts Ratings

Earnings Call Summary

Q4 2025
Earnings Call Date:Feb 12, 2026|
% Change Since:
|
Earnings Call Sentiment|Positive
The call conveyed predominantly positive operational and financial momentum: strong same-store and managed SHOP performance, robust investment activity with attractive initial yields, solid liquidity and conservative leverage metrics, and a mid-single-digit earnings growth guide for 2026. Notable headwinds include a sequential decline in triple-net cash NOI due to portfolio transitions, a one-time increase in G&A, decreased interest income versus prior quarter, lagging Holiday transition assets that create near-term catch-up risk, and continued competitive pressure and cap rate compression in the acquisition market. Management emphasized stable regulatory outlook and confidence in execution and infrastructure to scale SHOP operations.
Company Guidance
Sabra's 2026 guidance calls for net income of $0.60–$0.64 per share, FFO and normalized FFO of $1.49–$1.53, and AFFO and normalized AFFO of $1.55–$1.59 per share (midpoints imply ~5% normalized FFO/AFFO growth vs. 2025); it assumes no undisclosed 2026 dispositions or capital markets activity and no tenant revenue-recognition changes. Operational assumptions include triple‑net cash NOI growth at low single digits (midpoint, in line with contractual escalators) and average full‑year cash NOI growth for the same‑store managed senior housing portfolio in the low‑to‑mid teens. Expense and capital assumptions: G&A of ~ $52.0M at the midpoint (including $12.0M stock‑based comp), cash interest expense of ~$103.0M, and weighted average share counts of ~255.0M for normalized FFO and ~256.0M for normalized AFFO. Balance sheet and liquidity metrics cited: net debt/adjusted EBITDA 5.00x as of 12/31/2025 (down 0.27x YoY), cost of permanent debt 3.92%, weighted average remaining debt term 4.2 years, no permanent floating‑rate exposure, and ample liquidity of ~ $1.2B (cash $71.5M, revolver availability $782.4M, $322.7M outstanding under forwards) with $483.0M ATM capacity; the board also declared a $0.30 quarterly dividend (paid 2/27/2026), representing 79% of Q4 normalized AFFO per share.
Strong SHOP Operational Performance
Same-store managed senior housing revenue grew 6.4% year-over-year; same-store occupancy increased 160 basis points YoY to 87.9% (domestic 84.7% up 80 bps; Canada 94.2% up 300 bps). RevPOR rose 4.2% YoY (Canada +5.2%). Same-store cash NOI grew 12.6% YoY and XPOR increased 1.6% YoY.
Sequential Managed Portfolio Momentum
Total managed portfolio sequential revenue growth of 15.8% and cash NOI growth of 18.4% with margin expansion of 60 basis points, demonstrating meaningful quarter-to-quarter operational improvement.
Robust Investment Activity and Pipeline
Completed approximately $450,000,000 of investments in 2025 and added ~$150,000,000 during the quarter (four properties). Currently in process of closing ~$240,000,000 of awarded deals (mostly Q1/early Q2) and expect to materially exceed 2025 investment volume in 2026.
Attractive Initial Yields on New Acquisitions
2025 investments had an estimated initial cash yield of ~7.5% and average asset vintage under ten years, indicating relatively modern, income-generating acquisitions.
2026 Earnings Guidance – Midpoint Growth
Full-year 2026 guidance: normalized FFO per share $1.49–$1.53 and normalized AFFO per share $1.55–$1.59, which implies approximately 5% growth at the midpoint vs. 2025.
Solid Q4 Financials
Q4 2025 normalized debt FFO per share of $0.36 and normalized AFFO per share of $0.38; absolute normalized FFO and normalized AFFO totaled $91.2 million and $95.2 million, respectively. Managed senior housing cash NOI increased sequentially by $5.5 million to $35.6 million.
Strong Liquidity and Proactive Capital Strategy
Ample liquidity of approximately $1.2 billion (unrestricted cash $71.5M; revolver availability $782.4M; $322.7M under forward sales). Issued $206M on forward basis during quarter at an average price of $18.79; $322.7M outstanding under forwards at avg $18.60 after commissions.
Leverage and Cost of Debt Favorable
Net debt to adjusted EBITDA of 5.00x as of 12/31/2025 (down 0.27x year-over-year), cost of permanent debt 3.92%, and weighted-average term on permanent debt of 4.2 years with the next material maturity in 2028.
Dividend Declared and Coverage
Board declared a quarterly cash dividend of $0.30 per share to be paid 02/27/2026; dividend represents a payout of 79% of Q4 normalized AFFO per share and was described as adequately covered.

Sabra Healthcare REIT (DE:SBC) Earnings, Revenues Date & History

The upcoming earnings date is based on a company’s previous reporting, and may be updated when the actual date is announced

DE:SBC Earnings History

Report Date
Fiscal Quarter
Forecast / EPS
Last Year's EPS
EPS YoY Change
Press Release
Slides
Play Transcript
May 06, 2026
2026 (Q1)
0.14 / -
0.144
Feb 12, 2026
2025 (Q4)
0.14 / 0.09
0.161-42.11% (-0.07)
Nov 05, 2025
2025 (Q3)
0.15 / 0.08
0.11-30.77% (-0.03)
Aug 04, 2025
2025 (Q2)
0.15 / 0.23
0.085170.00% (+0.14)
May 05, 2025
2025 (Q1)
0.15 / 0.14
0.09354.55% (+0.05)
Feb 19, 2025
2024 (Q4)
0.14 / 0.16
0.059171.43% (+0.10)
Oct 31, 2024
2024 (Q3)
0.13 / 0.11
-0.059285.71% (+0.17)
Aug 07, 2024
2024 (Q2)
0.13 / 0.08
0.07611.11% (<+0.01)
May 08, 2024
2024 (Q1)
0.12 / 0.09
-0.034375.00% (+0.13)
Feb 27, 2024
2023 (Q4)
0.11 / 0.06
-0.313118.92% (+0.37)
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed

DE:SBC Earnings-Related Price Changes

Report Date
Price 1 Day Before
Price 1 Day After
Percentage Change
Feb 12, 2026
€15.99€16.93+5.90%
Nov 05, 2025
€14.98€14.81-1.13%
Aug 04, 2025
€14.91€15.02+0.70%
May 05, 2025
€14.12€14.10-0.17%
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.

FAQ

When does Sabra Healthcare Reit (DE:SBC) report earnings?
Sabra Healthcare Reit (DE:SBC) is schdueled to report earning on May 06, 2026, TBA (Confirmed).
    What is Sabra Healthcare Reit (DE:SBC) earnings time?
    Sabra Healthcare Reit (DE:SBC) earnings time is at May 06, 2026, TBA (Confirmed).
      Where can I see when companies are reporting earnings?
      You can see which companies are reporting today on our designated earnings calendar.
        What companies are reporting earnings today?
        You can see a list of the companies which are reporting today on TipRanks earnings calendar.
          What is the P/E ratio of Sabra Healthcare Reit stock?
          The P/E ratio of Sabra Healthcare REIT is N/A.
            What is DE:SBC EPS forecast?
            DE:SBC EPS forecast for the fiscal quarter 2026 (Q1) is 0.14.